EFTA02089394.pdf

To: From: Sent: Tue 12/2/2014 12:24:17 AM Subject: Re: Confidential Sure! Sent from my iPhonc On Dec I, 2014, at 7:21 PM, "James Meiskin" wrote: Can you please check to see if next week works for JE? Thank you, James From: Sent: Monday,loven To: James Meiskin Subject: Re: Confidential ok, thanks On Nov 3, 2014, at 11:05 AM, James Mciskin wrote: Thank you very much! I truly think that JE will enjoy meeting David, and he should also know that David is a substantive businessperson, who could also potentially get involved with opportunities/investments on his end as well. fames From: Sent: Monday, Noventer 1 11%.11 , li‘ 11M1 To: Subject: Re: Confidential Hi James...unfortunately I have not heard back from Jeffrey on this...but let me try again!! :) On Nov 3, 2014, at 8:05 AM, James Meiskin wrote: Hi Any word on when Jeffrey may have a brief window of time to meet with David Carter and myself, this week or next? David will also be meeting with the President of UBS when he is in NY, but is holding off on setting up that meeting until he gets a time from Jeffrey, so he can coordinate properly both meetings, and also make sure to see JE who he is excited to meet. Best, J From: EFTA_R1_00683801 EFTA02089394 Sent: Wednesday, October 29, 2014 9:39 AM To: Subject: Re: Confidential Great! thanks Jamcs...I will pass this along and hopefully Jeffrey will be available. Thank you, Lesley On Oct 29, 2014, at 8:15 AM, James Mciskin wrote: attached the updated deck for JE's review. David Carter would like to meet Jeffrey over the next several weeks if possible, and I think that they would have much in common on many levels, and that Jeffrey would find the meeting to be worthwhile. Please let me know. Thank you. James Dear James, Like I have said in an earlier email. I am looking for an "investing partner" to match (50%/50%) the money Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to develop a variety of technologies that are of interest to their country. For their investment they get commercialization rights to the technologies they finance for Russia and the CIS. For us, on the USA side, this is a major source of capital to start a series of companies that have great potential as therapeutic technologies, and we get commercialization rights for the USA, and rest of the world markets. Basically, we get the rights that are valuable to us at "half price". Over the next several years our plan is to identify seven/eight technologies that are worthy of development. RVC has already agreed to finance the first (MAJI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capital that thinks this is an interesting investment theme, and is willing to consider the idea as something they might want to implement. My belief is that there is more money in NYC, seeking an investment home, then there are "quality investment ideas". I could be wrong, but I have to believe that people running a lot of capital in New York would want to hear new, creative, and GOOD new investment ideas. I think this idea is the kind of idea that is worth a look, and worth serious consideration. I think we are talking $150M over a five year horizon. Best, David EFTA_R1_00683802 EFTA02089395  David W. Carter President—DaCart Capital LLC <DaCart Presentation Jul 7 2014.pdf> No virus found in this message. Checked by AVG - www zo.0 com Version: 2015.0.5557 I Virus Database: 4189/8501 - Release Date: I I /03/14 EFTA_R1_00683803 EFTA02089396